US approves breakthrough hepatitis C drug (Update)
U.S. health officials have approved a highly anticipated hepatitis C drug from Gilead Sciences Inc. that is expected to offer a faster, more palatable cure to millions of people infected with the liver-destroying virus.
Dec 6, 2013
0
0